Latest Content

Cancer in Two Acts

September 16th 2022, 9:00pm


I pretend I’m at a spa day as an oncology nurse in a hazmat suit unhooks me from the intravenous drip machine.

What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?

September 16th 2022, 7:00pm

By Brielle Benyon


Over the past five years, CAR-T cell therapy has improved outcomes for many patients with blood cancer. Here’s what patients need to know about the immune-based treatment.

Extra Years Together Meant We Aged Out of a Free Vacation for Families Affected by Cancer

September 16th 2022, 5:00pm

By Martha Carlson


Extra years with my family meant missing out on a free trip granted to patients with cancer who have children under the age of 18 — and I’m OK with that.

Some Health Appointments Will Be Delayed for Queen Elizabeth II’s Funeral, Ryan Reynolds Gets Colonoscopy and Has Potentially Pre-Cancerous Polyp Removed and More

September 16th 2022, 3:00pm

By Brielle Benyon


From the delay of some health care services in the United Kingdom due to Queen Elizabeth II’s funeral to actor Ryan Reynolds broadcasting his colonoscopy — including the finding of a pre-cancerous polyp — here’s what’s happening in the cancer space this week.

Studies Will Investigate Novel Drug in Colon and Skin Cancer

September 16th 2022, 1:00pm

By Brielle Benyon


Botensilimab will be evaluated in certain patients with colorectal cancer and melanoma, a type of skin cancer, in two recently launched clinical trials.

Men With Breast Cancer May Respond Less to Neoadjuvant Chemotherapy Versus Women

September 15th 2022, 9:00pm

By Miranda Lankas


Although rates of pathologic complete response to neoadjuvant — also known as presurgical — chemotherapy were lower in men than women with breast cancer, this may highlight an area of further research of treating this cancer in men.

As I Near the End of My Life With Metastatic Cancer, I’m Writing My Final Chapter

September 15th 2022, 7:00pm


As I face the end of my life due to metastatic colorectal cancer, I’m preparing my loved ones for my death — from determining who gets my stuff to writing my eulogy and making my memorial service playlist.

How I’ll Handle My Emotions as I Rebuild My Life After Cancer

September 15th 2022, 5:00pm

By Steve Rubin


Here’s how I plan to handle sadness, anger, loneliness, regret and guilt that comes with rebuilding my life after cancer.

Maintenance Therapy the 'Biggest Breakthrough in Decades' for Ovarian Cancer

September 15th 2022, 3:00pm

By Karen Blum


Although maintenance treatments have helped patients with ovarian cancer live longer, experts note there are still some unmet needs that must be addressed.

Chemotherapy Combination May Significantly Prolong Survival for Certain Patients With Pancreatic Cancer

September 15th 2022, 1:11pm

By Colleen Moretti


Compared with gemcitabine, a modified FOLFIRINOX regimen improved survival rates over five years of follow-up for patients with pancreatic ductal adenocarcinoma who underwent resection, although all patients may not be suitable for this treatment, an expert said.

8 Updates in the Childhood Cancer Space From 2022 You May Have Missed

September 14th 2022, 9:00pm

By Sailaja Darisipudi


In honor of Childhood Cancer Awareness Month in September, CURE® compiled a roundup of some of the top stories involving the latest updates in the pediatric cancer space that patients and their families may have missed.

Lumakras Improves Outcomes, Quality of Life in Patients With Lung Cancer Subtype

September 14th 2022, 7:00pm

By Silas Inman


Lumakras outperformed chemotherapy in reducing the risk of progression or death and improving quality of life for patients with KRAS G12C-mutated non-small cell lung cancer, study results showed.

My New, Side Effect-Free Cancer Treatment Makes Me Feel Like 'a Kid in a Toy Store'

September 14th 2022, 5:00pm

By Jane Biehl Ph.D.


My new cancer treatment hardly has any side effects, making me wonder if researchers are focusing on making their drugs more tolerable for patients.

Presurgical Opdivo-Yervoy Combo Has ‘Very Strong Potential’ to Be Standard of Care for Subgroup of Patients With Colon Cancer

September 14th 2022, 3:00pm

By Dylann Cohn-Emery


None of the more than 100 evaluable patients with mismatch repair deficient colon cancer have experienced disease recurrence after treatment with presurgical Opdivo plus Yervoy, according to study results.

Second-Line Treatment With Libtayo May Improve Long-Term Survival in Subset of Patients With Cervical Cancer

September 14th 2022, 1:00pm

By Darlene Dobkowski, MA


Treatment with Libtayo may improve survival over a 30-month period with no new side effects in patients with recurrent or metastatic cervical cancer, opening the doors for an immunotherapy option for these patients.